Patents by Inventor Roger W. Wiseman
Roger W. Wiseman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8715335Abstract: An implantable endoluminal device that is fabricated from materials that present a blood or body fluid and tissue contact surface that has controlled heterogeneities in material constitution. An endoluminal stent-graft and web-stent that is made of an monolithic material deposited into a monolayer and etched into regions of structural members and web regions subtending interstitial regions between the structural members. An endoluminal graft is also provided which is made of a biocompatible metal or metal-like material. The endoluminal stent-graft is characterized by having controlled heterogeneities in the stent material along the blood flow surface of the stent and the method of fabricating the stent using vacuum deposition methods.Type: GrantFiled: January 5, 2010Date of Patent: May 6, 2014Assignee: Advanced Bio Prosthetic Surfaces, Ltd., a wholly owned subsidiary of Palmaz Scientific, Inc.Inventors: Julio C. Palmaz, Christopher T. Boyle, Christopher E. Banas, Roger W. Wiseman, Denes Marton
-
Patent number: 8083908Abstract: A vacuum deposition method for fabricating high-strength nitinol films by sputter depositing nickel and titanium from a heated sputtering target, and controlling the sputter deposition process parameters in order to create high-strength nitinol films that exhibit shape memory and/or superelastic properties without the need for precipitation annealing to attenuate the transition conditions of the deposited material. A vacuum deposited nitinol film having high-strength properties equal to or better than wrought nitinol films and which are characterized by having non-columnar crystal grain structures.Type: GrantFiled: October 19, 2007Date of Patent: December 27, 2011Assignee: Advanced Bio Prosthetic Surfaces, Ltd.Inventors: Denes Marton, Christopher T. Boyle, Roger W. Wiseman, Christopher E. Banas
-
Publication number: 20100191317Abstract: An implantable endoluminal device that is fabricated from materials that present a blood or body fluid and tissue contact surface that has controlled heterogeneities in material constitution. An endoluminal stent-graft and web-stent that is made of an monolithic material deposited into a monolayer and etched into regions of structural members and web regions subtending interstitial regions between the structural members. An endoluminal graft is also provided which is made of a biocompatible metal or metal-like material. The endoluminal stent-graft is characterized by having controlled heterogeneities in the stent material along the blood flow surface of the stent and the method of fabricating the stent using vacuum deposition methods.Type: ApplicationFiled: January 5, 2010Publication date: July 29, 2010Applicant: Advanced Bio Prosthetic Surfaces, Ltd., A Wholly owned subsidiary of Palmaz Scientific, Inc.Inventors: Julio C. Palmaz, Christopher T. Boyle, Christopher E. Banas, Roger W. Wiseman, Denes Marton
-
Patent number: 7670690Abstract: A vacuum deposition method for fabricating high-strength nitinol films by sputter depositing nickel and titanium from a heated sputtering target, and controlling the sputter deposition process parameters in order to create high-strength nitinol films that exhibit shape memory and/or superelastic properties without the need for precipitation annealing to attenuate the transition conditions of the deposited material. A vacuum deposited nitinol film having high-strength properties equal to or better than wrought nitinol films and which are characterized by having non-columnar crystal grain structures.Type: GrantFiled: October 19, 2007Date of Patent: March 2, 2010Assignee: Advanced Bio Prosthetic Surfaces, Ltd.Inventors: Denes Marton, Christopher T. Boyle, Roger W. Wiseman, Christopher E. Banas
-
Patent number: 7641680Abstract: An implantable endoluminal device that is fabricated from materials that present a blood or body fluid and tissue contact surface that has controlled heterogeneities in material constitution. An endoluminal stent-graft and web-stent that is made of an monolithic material deposited into a monolayer and etched into regions of structural members and web regions subtending interstitial regions between the structural members. An endoluminal graft is also provided which is made of a biocompatible metal or metal-like material. The endoluminal stent-graft is characterized by having controlled heterogeneities in the stent material along the blood flow surface of the stent and the method of fabricating the stent using vacuum deposition methods.Type: GrantFiled: November 6, 2002Date of Patent: January 5, 2010Assignee: Advanced Bio Prosthetic Surfaces, Ltd.Inventors: Julio C. Palmaz, Christopher T. Boyle, Christopher E. Banas, Roger W. Wiseman, Denes Marton
-
Patent number: 7625594Abstract: An implantable endoluminal device which is fabricated from materials which present a blood or body fluid and tissue contact surface which has controlled heterogeneities in material constitution. An endoluminal stent which is made of a material having controlled heterogeneities in the stent material along the blood flow surface of the stent and the method of fabricating the stent using vacuum deposition methods.Type: GrantFiled: November 22, 2004Date of Patent: December 1, 2009Assignee: Advanced Bio Prosthetic Surfaces, Ltd.Inventors: Julio C. Palmaz, Eugene A. Sprague, Cristina Simon, Denes Marton, Roger W. Wiseman, Christopher E. Banas
-
Patent number: 7491226Abstract: An implantable endoluminal device that is fabricated from materials that present a blood or body fluid and tissue contact surface that has controlled heterogeneities in material constitution. An endoluminal stent-graft and web-stent that is made of an monolithic material deposited into a monolayer and etched into regions of structural members and web regions subtending interstitial regions between the structural members. An endoluminal graft is also provided which is made of a biocompatible metal or metal-like material. The endoluminal stent-graft is characterized by having controlled heterogeneities in the stent material along the blood flow surface of the stent and the method of fabricating the stent using vacuum deposition methods.Type: GrantFiled: November 6, 2002Date of Patent: February 17, 2009Assignee: Advanced Bio Prosthetic Surfaces, Ltd.Inventors: Julio C. Palmaz, Christopher T. Boyle, Christopher E. Banas, Roger W. Wiseman, Denes Marton
-
Publication number: 20080171214Abstract: A vacuum deposition method for fabricating high-strength nitinol films by sputter depositing nickel and titanium from a heated sputtering target, and controlling the sputter deposition process parameters in order to create high-strength nitinol films that exhibit shape memory and/or superelastic properties without the need for precipitation annealing to attenuate the transition conditions of the deposited material. A vacuum deposited nitinol film having high-strength properties equal to or better than wrought nitinol films and which are characterized by having non-columnar crystal grain structures.Type: ApplicationFiled: October 19, 2007Publication date: July 17, 2008Applicant: Advanced Bio Prosthetic Surfaces, Ltd.Inventors: Denes Marton, Christopher T. Boyle, Roger W. Wiseman, Christopher E. Banas
-
Patent number: 7335426Abstract: A vacuum deposition method for fabricating high-strength nitinol films by sputter depositing nickel and titanium from a heated sputtering target, and controlling the sputter deposition process parameters in order to create high-strength nitinol films that exhibit shape memory and/or superelastic properties without the need for precipitation annealing to attenuate the transition conditions of the deposited material. A vacuum deposited nitinol film having high-strength properties equal to or better than wrought nitinol films and which are characterized by having non-columnar crystal grain structures.Type: GrantFiled: August 2, 2002Date of Patent: February 26, 2008Assignee: Advanced Bio Prosthetic Surfaces, Ltd.Inventors: Denes Marton, Christopher T. Boyle, Roger W. Wiseman, Christopher E. Banas
-
Patent number: 7195641Abstract: This invention relates to improvements in prosthetic cardiac and venous valves and implantable medical devices having moveable septa. The inventive prosthetic cardiac and venous valves have metallic or pseudometallic valves coupled to metallic or pseudometallic stents that permit percutaneous delivery of the devices.Type: GrantFiled: April 11, 2002Date of Patent: March 27, 2007Assignee: Advanced Bio Prosthetic Surfaces, Ltd.Inventors: Julio C. Palmaz, Eugene A. Sprague, Cristina Fuss, Denes Marton, Roger W. Wiseman, Christopher E. Banas, Christopher T. Boyle, Steven R. Bailey
-
Patent number: 6820676Abstract: An implantable endoluminal device which is fabricated from materials which present a blood or body fluid and tissue contact surface which has controlled heterogeneities in material constitution. An endoluminal stent which is made of a material having controlled heterogeneities in the stent material along the blood flow surface of the stent and the method of fabricating the stent using vacuum deposition methods.Type: GrantFiled: December 22, 2000Date of Patent: November 23, 2004Assignee: Advanced Bio Prosthetic Surfaces, Ltd.Inventors: Julio C. Palmaz, Eugene A. Sprague, Cristina Simon, Denes Marton, Roger W. Wiseman, Christopher E. Banas
-
Publication number: 20030130718Abstract: An implantable endoluminal device that is fabricated from materials that present a blood or body fluid and tissue contact surface that has controlled heterogeneities in material constitution. An endoluminal stent-graft and web-stent that is made of an monolithic material deposited into a monolayer and etched into regions of structural members and web regions subtending interstitial regions between the structural members. An endoluminal graft is also provided which is made of a biocompatible metal or metal-like material. The endoluminal stent-graft is characterized by having controlled heterogeneities in the stent material along the blood flow surface of the stent and the method of fabricating the stent using vacuum deposition methods.Type: ApplicationFiled: November 6, 2002Publication date: July 10, 2003Inventors: Julio C. Palmas, Christopher T. Boyle, Christopher E. Banas, Roger W. Wiseman, Denes Marton
-
Publication number: 20030074053Abstract: An implantable endoluminal device that is fabricated from materials that present a blood or body fluid and tissue contact surface that has controlled heterogeneities in material constitution. An endoluminal stent-graft and web-stent that is made of an monolithic material deposited into a monolayer and etched into regions of structural members and web regions subtending interstitial regions between the structural members. An endoluminal graft is also provided which is made of a biocompatible metal or metal-like material. The endoluminal stent-graft is characterized by having controlled heterogeneities in the stent material along the blood flow surface of the stent and the method of fabricating the stent using vacuum deposition methods.Type: ApplicationFiled: November 6, 2002Publication date: April 17, 2003Inventors: Julio C. Palmaz, Christopher T. Boyle, Christopher E. Banas, Roger W. Wiseman, Denes Marton
-
Patent number: 6537310Abstract: An implantable endoluminal device that is fabricated from materials that present a blood or body fluid and tissue contact surface that has controlled heterogeneities in material constitution. An endoluminal stent-graft and web-stent that is made of an monolithic material deposited into a monolayer and etched into regions of structural members and web regions subtending interstitial regions between the structural members. An endoluminal graft is also provided which is made of a biocompatible metal or metal-like material. The endoluminal stent-graft is characterized by having controlled heterogeneities in the stent material along the blood flow surface of the stent and the method of fabricating the stent using vacuum deposition methods.Type: GrantFiled: March 20, 2000Date of Patent: March 25, 2003Assignee: Advanced Bio Prosthetic Surfaces, Ltd.Inventors: Julio C. Palmaz, Christopher T. Boyle, Christopher E. Banas, Roger W. Wiseman, Denes Marton
-
Publication number: 20030023303Abstract: This invention relates to improvements in prosthetic cardiac and venous valves and implantable medical devices having moveable septa. The inventive prosthetic cardiac and venous valves have metallic or pseudometallic valves coupled to metallic or pseudometallic stents that permit percutaneous delivery of the devices.Type: ApplicationFiled: April 11, 2002Publication date: January 30, 2003Inventors: Julio C. Palmaz, Eugene A Sprague, Cristina Fuss (formerly Simon), Denes Marton, Roger W. Wiseman, Christopher E. Banas, Christopher T. Boyle, Steven R. Bailey
-
Patent number: 6379383Abstract: An implantable endoluminal device which is fabricated from materials which present a blood or body fluid and tissue contact surface which has controlled heterogeneities in material constitution. An endoluminal stent which is made of a material having controlled heterogeneities in the stent material along the blood flow surface of the stent and the method of fabricating the stent using vacuum deposition methods.Type: GrantFiled: November 19, 1999Date of Patent: April 30, 2002Assignee: Advanced Bio Prosthetic Surfaces, Ltd.Inventors: Julio C. Palmaz, Eugene A. Sprague, Cristina Simon, Denes Marton, Roger W. Wiseman, Christopher E. Banas
-
Publication number: 20010001834Abstract: An implantable endoluminal device which is fabricated from materials which present a blood or body fluid and tissue contact surface which has controlled heterogeneities in material constitution. An endoluminal stent which is made of a material having controlled heterogeneities in the stent material along the blood flow surface of the stent and the method of fabricating the stent using vacuum deposition methods.Type: ApplicationFiled: December 22, 2000Publication date: May 24, 2001Inventors: Julio C. Palmaz, Eugene A. Sprague, Cristina Simon, Denes Marton, Roger W. Wiseman, Christopher E. Banas
-
Patent number: 6162897Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human breast and ovarian cancer predisposing gene (BRCA1), some mutant alleles of which cause susceptibility to cancer, in particular breast and ovarian cancer. More specifically, the invention relates to germline mutations in the BRCA1 gene and their use in the diagnosis of predisposition to breast and ovarian cancer. The present invention further relates to somatic mutations in the BRCA1 gene in human breast and ovarian cancer and their use in the diagnosis and prognosis of human breast and ovarian cancer. Additionally, the invention relates to somatic mutations in the BRCA1 gene in other human cancers and their use in the diagnosis and prognosis of human cancers. The invention also relates to the therapy of human cancers which have a mutation in the BRCA1 gene, including gene therapy, protein replacement therapy and protein mimetics.Type: GrantFiled: May 2, 1997Date of Patent: December 19, 2000Assignees: Myriad Genetics, Inc., University of Utah Research Foundation, The United States of America as represented by the Department of Health and Human ServicesInventors: Mark H. Skolnick, David E. Goldgar, Yoshio Miki, Jeff Swenson, Alexander Kamb, Keith D. Harshman, Donna M. Shattuck-Eidens, Sean V. Tavtigian, Roger W. Wiseman, P. Andrew Futreal
-
Patent number: 5753441Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human breast and ovarian cancer predisposing gene (BRCA1), some mutant alleles of which cause susceptibility to cancer, in particular breast and ovarian cancer. More specifically, the invention relates to germline mutations in the BRCA1 gene and their use in the diagnosis of predisposition to breast and ovarian cancer. The present invention further relates to somatic mutations in the BRCA1 gene in human breast and ovarian cancer and their use in the diagnosis and prognosis of human breast and ovarian cancer. Additionally, the invention relates to somatic mutations in the BRCA1 gene in other human cancers and their use in the diagnosis and prognosis of human cancers. The invention also relates to the therapy of human cancers which have a mutation in the BRCA1 gene, including gene therapy, protein replacement therapy and protein mimetics.Type: GrantFiled: January 5, 1996Date of Patent: May 19, 1998Assignees: Myriad Genetics, Inc., University of Utah Research Foundation, The United States of America as represented by the Department of Health and Human ServicesInventors: Mark H. Skolnick, David E. Goldgar, Yoshio Miki, Jeff Swenson, Alexander Kamb, Keith D. Harshman, Donna M. Shattuck-Eidens, Sean V. Tavtigian, Roger W. Wiseman, P. Andrew Futreal
-
Patent number: 5747282Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human breast and ovarian cancer predisposing gene (BRCA1), some mutant alleles of which cause susceptibility to cancer, in particular breast and ovarian cancer. More specifically, the invention relates to germline mutations in the BRCA1 gene and their use in the diagnosis of predisposition to breast and ovarian cancer. The present invention further relates to somatic mutations in the BRCA1 gene in human breast and ovarian cancer and their use in the diagnosis and prognosis of human breast and ovarian cancer. Additionally, the invention relates to somatic mutations in the BRCA1 gene in other human cancers and their use in the diagnosis and prognosis of human cancers. The invention also relates to the therapy of human cancers which have a mutation in the BRCA1 gene, including gene therapy, protein replacement therapy and protein mimetics.Type: GrantFiled: June 7, 1995Date of Patent: May 5, 1998Assignees: Myraid Genetics, Inc., University of Utah Research Foundation, The United States of America as represented by the Secretary of Health and Human ServicesInventors: Mark H. Skolnick, David E. Goldgar, Yoshio Miki, Jeff Swenson, Alexander Kamb, Keith D. Harshman, Donna M. Shattuck-Eidens, Sean V. Tavtigian, Roger W. Wiseman, P. Andrew Futreal